|
1.
|
World Health Organization (WHO): Cancer
prevention and control; report to the secretariat by the 58th World
Health Assembly. http://www.who.int/mediacentre/news/releases/2005/pr_wha05/en/index.html.
Accessed January 23, 2012.
|
|
2.
|
WHO: The global burden of disease: 2004
update. Geneva: pp. 1–150. 2008
|
|
3.
|
WHO world health statistics 2009:
Cause-specific mortality and morbidity. http://www.who.int/whosis/whostat/EN_WHS09_Table2.pdf.
Accessed January 23, 2012.
|
|
4.
|
WHO world health statistics: Cameroon
factsheets of health statistics 2010 and Non Communicable Disease
Country Profiles, 2011. http://www.afro.who.int/.
Accessed January 23, 2012.
|
|
5.
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. July 3–2012.(Epub ahead of
print).
|
|
6.
|
Njoumemi Z, Sibetcheu D, Ekoe T and Gbedji
E: Tobacco in Cameroon from farming to control in Africa tobacco
situational analysis. https://www.atsa.org. Accessed January
18, 2012.
|
|
7.
|
Jemal A, Bray F, Forman D, O’Brien M,
Ferlay J, Center M and Parkin DM: Cancer burden in Africa and
opportunities for prevention. Cancer. 118:4372–4384. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jemal A, Bray F, Ferlay J, Ward E and
Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90.
2011. View Article : Google Scholar
|
|
9.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers CD and Parkin DM: GLOBOCAN 2008: Cancer Incidence,
Mortality and Prevalence Worldwide in 2008. http://globocan.iarc.fr.
Accessed June 17, 2012.
|
|
11.
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006.PubMed/NCBI
|
|
12.
|
Parkin DM, Sitas F, Phil D, Chirenje M,
Stein L, Abratt R and Wabinga H: Part I: Cancer in indigenous
Africans - burden, distribution, and trends. Lancet Oncol.
9:683–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Frenk J, Bobadilla J, Sepùlveda J and
Cervantes ML: Health transition in middle-income countries: new
challenges for health care. Health Policy Plan. 4:29–39. 1989.
View Article : Google Scholar
|
|
14.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers CD and Parkin D: GLOBOCAN 2008: Cancer Incidence and
Mortality Worldwide. IARC CancerBase No. 10. Lyon, France: IARC;
2010, http://globocan.iarc.fr.
2010. Accessed June 17, 2012.
|
|
15.
|
Ndom P, Germaine U, Bell EMD, Eloundou A,
Hossain N and Huo D: Characterization of male breast cancer in
Yaoundé, Cameroon and a meta-analysis of literature in Africa.
1–15. 2007.
|
|
16.
|
Hippolyte KW, Kowa TK, Lonfouo AN, Tchinda
AT, Tane P, Kikuchi H, Frédérich M and Oshima Y: Phenolic compounds
and terpenoids from hypericum lanceolatum. Rec Nat Prod. 6:94–100.
2012.
|
|
17.
|
Lenta BN, Tantangmo F, Devkota KP, Wansi
JD, Chouna JR, Soh RC, Neumann B, Stammler HG, Tsamo E and Sewald
N: Bioactive constituents of the stem bark of beilschmiedia
zenkeri. J Nat Prod. 72:2130–2134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kuete V, Mbaveng AT, Tsaffack M, Beng VP,
Etoa FX, Nkengfack AE, Meyer MJJ and Lall N: Antitumor, antioxidant
and antimicrobial activities of Bersama
engleriana(melianthaceae). J Ethnopharmacol. 115:494–501. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kuete V, Vouffo B, Mbaveng AT, Vouffo EY,
Siagat RM and Dongo E: Evaluation of Antiaris africana
methanol extract and compounds for antioxidant and antitumor
activities. Pharm Biol. 47:1042–1049. 2009.
|
|
20.
|
Enow-Orock GE, Ndom P, Essame-Oyono JL and
Doh AS: Cancer incidence in Yaounde 2004–2008: Yaoundé cancer
registry technical report. Yaoundé: National Cancer Control
Program, Cameroon; pp. 26–27. 2009
|
|
21.
|
United state development service (USDS):
2010, http://www.hhs.gov/secretary/about/priorities/strategicplan2010-2015.pdf
and http://www.cdc.gov/nchs/data/hus/hus10.pdf.
Accessed September 5, 2012.
|
|
22.
|
UK border and immigration service’s 2008:
Country of origin information report. http://supportkurds.org/reports/new-home-officeuk-borders-agency-country-of-origin-information-report.
Accessed August 26, 2012.
|
|
23.
|
African development bank country strategy
papers 2010–2014: Cameroon regional departments center: 2–8,
2009.
|
|
24.
|
World development indicators.
International Bank for Reconstruction and Development/The World
Bank; Washington, DC: 2009
|
|
25.
|
Cameroon - ministry of economy and
finance. Memorandum No. 07/788, 2010.
|
|
26.
|
Barton MB, Frommer M and Shafiq J: Role of
radiotherapy in cancer control in low-income and middle-income
countries. Lancet Oncol. 7:586–595. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Fezeu L, Fointama E, Ngufor G, Mbeh G and
Mbanya JC: Diabetes awareness in general population in Cameroon.
Diabetes Res Clin Pract. 90:312–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Mbeh GN, Edwards R, Ngufor G, Assah F,
Fezeu L and Mbanya JC: Traditional healers and diabetes: results
from a pilot project to train traditional healers to provide health
education and appropriate health care practices for diabetes
patients in Cameroon. Glob Health Promot. 17(Suppl 2): 17–26. 2010.
View Article : Google Scholar
|
|
29.
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the last 25 years. J Nat Prod.
70:461–477. 2007.PubMed/NCBI
|
|
30.
|
Hostettmann K, Marston A, Ndjoko K and
Wolfender JL: The potential of African plants as source of drugs.
Curr Org Chem. 4:973–1010. 2000.
|
|
31.
|
Mbakop A, Oyono EJL, Ngbangako MC and
Abondo A: Current epidemiology of cancers in cameroon (Central
Africa). Bull Cancer. 79:1101–1104. 1992.(In French).
|
|
32.
|
Doh AS, Nkele NN, Achu P, Essimbi F,
Essame O and Nkegoum B: Visual inspection with acetic acid and
cytology as screening methods for cervical lesions in Cameroon. Int
J Gynaecol Obstet. 89:167–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Suba EJ and Raab SS: Population-based Pap
screening in Cameroon. Acta Cytol. 47:948–949. 2003.PubMed/NCBI
|
|
34.
|
Robyr R, Nazeer S, Vassilakos P, Matute
JC, Sando Z, Halle G, Mbakop A and Campana A: Feasibility of
cytology-based cervical cancer screening in rural Cameroon. Acta
Cytol. 46:1110–1116. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Enow-Orock G, Mbu R, Ngowe NM, Tabung FK,
Mboudou E, Ndom P, Nkele N, Takang W, Essame-Oyono JL and Doh A:
Gynecological cancer profile in the Yaounde population, Cameroon.
Clin Mother Child Health. 3:437–444. 2006.
|
|
36.
|
Kemfang JDN, Yomi J, Kasia JM, Mawamba Y,
Ekortarh AC and Vlastos G: Breast cancer profile in a group of
patients followed up at the Radiation Therapy Unit of the Yaounde
General Hospital, cameroon. Int J Gynaecol Obstet.
2011:1435062011.PubMed/NCBI
|
|
37.
|
Tebeu PM, Petignat P and Mhawech-Fauceglia
P: Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol
Obstet. 104:148–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Eniu A, Carlson RW, Aziz Z, Bines J,
Hortobágyi GN, Bese NS, Love RR, Vikram B, Kurkure A and Anderson
BO: Breast cancer in limited resource countries; treatment and
allocation of resources. Breast J. 12(Suppl 1): S38–S53.
2006.PubMed/NCBI
|
|
39.
|
Simpson D: Cameroon-disappearing ads mark
good start. Tob Control. 16:295–296. 2007.
|
|
40.
|
Drope J: The politics of smoke-free
policies in developing countries: Lessons from Africa. CVD Prev
Control. 5:65–73. 2010. View Article : Google Scholar
|
|
41.
|
Ezzati M, Henley SJ, Lopez AD and Thun MJ:
Role of smoking in global and regional cancer epidemiology- current
patterns and data needs. Int J Cancer. 116:963–971. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Mfoundi department, Cameroon: Memorandum
No. 1913. 2007
|
|
43.
|
Africa tobacco situational analyses (ATSA)
project 105799. https://www.idrc.ca/en/ev-155993-201_105799-1-IDRC_ADM_INFO.html.
Accessed July 11, 2012.
|
|
44.
|
Law framework on consumer protection in
cameroon. http://www.legicam.org/index.php.
Accessed July 11, 2012.
|
|
45.
|
Sankaranarayanan R, Swaminathan R, Brenner
H, et al: Cancer survival in Africa, Asia, and Central America: a
population-based study. Lancet Oncol. 11:165–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Levin V and Tatsuzaki H: Radiotherapy
services in countries in transition-gross national income per
capita as a significant factor. Radiother Oncol. 63:147–150. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
John R and Ross H: The global economic
cost of cancer, American cancer society, september, 2010.
http://www.cancer.org/AboutUs/GlobalHealth/global-economic-cost-of-cancer-report.
Accessed July 23, 2012.
|
|
48.
|
Djoyum B: journal Le jour. Cameroun.
12:2007.
|
|
49.
|
Ahmad K: Millions in developing world
deprived of radiotherapy. Lancet Oncol. 4:4562003. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Boik J: Natural Compounds in Cancer
Therapy. Oregon Medical Press; Princeton, MN, USA: 2001
|
|
51.
|
Stévigny C, Bailly C and Quetin-Leclercq
J: Cytotoxic and antitumor potentialities of aporphinoid alkaloids.
Curr Med Chem Anticancer Agents. 5:173–182. 2005.PubMed/NCBI
|
|
52.
|
Voss C, Eyol E and Berger MR:
Identification of potent anti-cancer activity in Ximenia
americana aqueous extracts used by African traditional
medicine. Toxicol Appl Pharmacol. 211:177–187. 2006.
|
|
53.
|
Whelan LC and Ryan MF: Ethanolic extracts
of Euphorbia and other ethnobotanical species as inhibitors
of human tumour cell growth. Phytomedicine. 10:53–58. 2003.
|
|
54.
|
Kuete V, Wabo HK, Eyong KO, Feussi MT,
Wiench B, Krusche BB, Tane P, Folefoc GN and Efferth T: Anticancer
activities of six selected natural compounds of some Cameroonian
medicinal plants. PLoS ONE. 6:e217622011. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Kuete V and Efferth T: Cameroonian
medicinal plants: pharmacology and derived natural products. Front
Pharmacol. 1:1232010. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Pieme CA, Penlap VN, Ngogang J and
Costache M: In vitro cytotoxicity and antioxidant activities of
five medicinal plants of Malvaceae family from Cameroon. Environ
Toxicol Pharmacol. 29:223–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Eyong KO, Kumar PS, Kuete V, Folefoc GN,
Nkengfack AE and Baskaran S: Semisynthesis and antitumoral activity
of 2-acetylfuranonaphthoquinone and other naphthoquinone
derivatives from lapachol. Bioorg Med Chem Lett. 18:5387–5390.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Nkengfack A, Azebaze AG, Waffo AK, Fomum
ZT, Meyer M and Heerden VF: Cytotoxic isoflavones from Erythrina
indica. Phytochemistry. 58:1113–1120. 2001. View Article : Google Scholar
|
|
59.
|
Nkengfack AE, Mkounga P, Fomum ZT, Meyer M
and Bodo B: Globulixanthones A and B, two new cytotoxic xanthones
with isoprenoid groups from the root bark of Symphonia
globulifera. J Nat Prod. 65:734–736. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Fotie J, Bohle DS, Olivier M, Gomez MA and
Nzimiro S: Trypanocidal and antileishmanial dihydrochelerythrine
derivatives from Garcinia lucida. J Nat Prod. 70:1650–1653.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Jiofack T, Fokunang C, Kemeuze V,
Fongnzossie E, Tsabang N, Nkuinkeu R, Mapongmetsem PM and
Nkongmeneck BA: Ethnobotany and phytopharmacopoea of the South-West
ethnoecological region of Cameroon. J Med Plants Res. 2:197–206.
2008.
|
|
62.
|
Jiofack T, Fokunang C, Guedje N, Kemeuze
V, Fongnzossie E, Nkongmeneck BA, Mapongmetsem PM and Tsabang N:
Ethnobotanical uses of medicinal plants of two ethnoecological
regions of cameroon. Int J Med Med Sci. 2:60–79. 2010.
|
|
63.
|
Focho DA, Ndam WT and Fonge BA: Medicinal
plants of Aguambu-Bamumbu in the Lebialem highlands, southwest
province of Cameroon. Afr J Pharm Pharacol. 3:1–13. 2009.
|
|
64.
|
Bodeker G: Traditional health knowledge
and public policy. Nature and Resource. 30:5–16. 1994.
|
|
65.
|
UNESCO: Traditional knowledge in tropical
environment. Nature and Resource. 30:1994.
|
|
66.
|
Posey DA and Dutfield G: Beyond
Intellectual Property -Towards Traditional Resource Rights for
Indigenous Peoples and Local Communities. Ottawa, Canada:
International Development Research Center; 1996
|
|
67.
|
Wambebe C: Development and production of
standardised phytomedicines. National Institute for Pharmaceutical;
Abuja, Nigeria: 1998
|
|
68.
|
McCarey C, Pirek D, Tebeu PM, Boulvain M,
Doh AS and Petignat P: Awareness of HPV and cervical cancer
prevention among Cameroonian healthcare workers. BCM Womens Health.
11:452011. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Angwafo FF III, Zaher A, Befidi-Mengue R,
Wonkam A, Takougang I, Powell I and Murphy G: High-grade
intra-epithelial neoplasia and prostate cancer in dibombari,
Cameroon. Prostate Cancer Prostatic Dis. 6:34–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Sow M, Nkégoum B, Oyono JL, Garoua and
Nzokou A: Epidemiological and histological features of urogenital
tumours in Cameroon. Prog Urol. 16:36–39. 2006.(In French).
|
|
71.
|
WHO technical report series 863. Annex 11
guidelines for the assessment of herbal medicines. pp. 178–183.
1996
|
|
72.
|
The international network for cancer
treatment and research (INCTR): http://www.inctr.org/.
Accessed June 23, 2012.
|
|
73.
|
International agency for research on
cancer (IARC) world health organization: Globocam 2008 section of
cancer information. https://www.iarc.fr. Accessed May 10,
2012.
|
